Janet Downie – CEO, Roslin CT, UK
17.09.2018
Related Interviews
Zack Pemberton-Whiteley – CEO, Leukaemia Care
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient and patient organizations’ involvement in the decision-making process for therapy appraisals, the use of HTA,…
Jonny Ohlson – CEO, Touchlight, UK
Jonny Ohlson, founder & CEO of Touchlight, discusses the genetic medicine revolution and the role of Touchlight in disrupting the field with its revolutionary DNA technology. You founded Touchlight Genetics…
Kathy Pritchard-Jones – President, International Society of Paediatric…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the International Society of Paediatric Oncology (SIOP) discusses the latest advancements in childhood cancer treatment, the…
Vaccines / Soriot Declares Pandemic Over: AstraZeneca to Start Charging for Its Shot
After a tumultuous year, AstraZeneca is creating a standalone vaccine unit and will begin to charge for its COVID-19 vaccine shot, having previously provided it at cost. PharmaBoardroom looks back…
Europe / Sustainability & Pharma Procurement: Are You ‘Green’ Enough?
In the wake of the 2021 United Nations Climate Change Conference (COP26), sustainability is once more a hot-button issue across all industries, including pharma. Here, Marco Rauland, vice president global…
UK / AstraZeneca Creates COVID Vaccines Unit; GSK Profit Forecast Up; Almac’s Northern Irish Expansion
The latest news from UK pharma, including AstraZeneca’s decision to create a dedicated business unit for its COVID-19 vaccines, GSK’s raised profits forecast, and CDMO Almac’s move to create over…
Latest Report
